Monday, July 6, 2020
News
NEWS HOME
PRN INDIA
TauRx Reveals Study Results That Offers New Hope for Treatment of Patients With Dementia
  SocialTwist Tell-a-Friend  
   

Minimum dose of hydromethylthionine could slow clinical decline and brain atrophy in behavioural variant Fronto-Temporal Dementia as well as Alzheimer's Disease

ABERDEEN, Scotland and SINGAPORE, May 19, 2020 /PRNewswire/ -- In a paper published online in the Journal of Alzheimer's Disease (https://doi.org/10.3233/JAD-191173), TauRx reported that the drug it is developing for the treatment of Alzheimer's disease (hydromethylthionine) also has significant pharmacological activity in behavioural variant Fronto-Temporal Dementia (bvFTD). The study reports a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in 176 patients with bvFTD. The results showed that, even at the lowest dose of hydromethylthionine tested (8 mg/day), the drug (taken as a tablet) produced statistically significant concentration-dependent effects on clinical decline and brain atrophy with results similar to those reported recently in Alzheimer's Disease (AD).

Professor George Perry, Editor-in-Chief of Journal of Alzheimer's Disease, commented: "This is the first report of a drug that has pharmacological activity on clinical decline and brain atrophy in bvFTD. The data now available in two different diseases highlight the potential of hydromethylthionine as an important new avenue for treatment of neurodegenerative diseases."

Hydromethylthionine blocks abnormal aggregation in the brain of the proteins linked to over 80% of bvFTD (tau protein and TDP-43 protein).1 A global Phase 3 clinical trial was conducted in 220 patients meeting international consensus criteria for a diagnosis of bvFTD1 who also had definite evidence of brain atrophy on their brain scan. Hydromethylthionine was tested at doses of 200 mg/day against a low dose of 8 mg/day which was intended only as a control to mask the discolouration of urine that can sometimes occur with the drug. The study design was based on the findings from an earlier trial in AD that used a different variant of the drug.2 As in the recently reported hydromethylthionine trials in AD, there was no difference between the high dose and the low dose on any of the clinical outcomes in the trial.3,4

To explore these results further, the researchers conducted a pharmacokinetic population analysis using plasma concentration data from patients who participated in the trial to measure how blood levels of the drug relate to its effects on the brain. Of the 220 patients initially randomised to the trial, blood samples and outcome data at baseline and at 12 months were available for 176. Using a new assay, the researchers found that the effects of hydromethylthionine at the 8 mg/day dose were determined by the blood level, and that the majority of patients had high enough blood levels of the drug even at this low dose to reduce clinical decline and brain atrophy by about half over 12 months compared to those with minimal blood levels. The high dose of 200 mg/day gave no additional benefit. The analyses suggest that a dose of about 30 mg/day would be optimal for treating bvFTD and could reduce the rate of disease progression even more. TauRx now plans to test this dose in a placebo-controlled confirmatory trial.

The analysis also showed that the concentration-response profile in bvFTD is similar to that recently reported in AD.5 Disease progression is linked to abnormal aggregation of Tau and TDP-43 proteins inside nerve cells in the brain in both diseases. The present results support the idea that hydromethylthionine works in a similar way in both AD and bvFTD.

Prof. Claude Wischik, of Aberdeen University and executive chairman of TauRx Therapeutics Ltd. commented: "These new results, coming as they do on top of the similar results we recently reported in AD, provide independent confirmation that hydromethylthionine has important pharmacological activity on brain structure and function in neurodegenerative diseases caused by abnormal protein aggregation. The results in bvFTD now give us the confidence to progress with a further confirmatory trial which we hope to begin recruiting early next year. A confirmatory trial in AD is already under way."

Professor Serge Gauthier, Director of the Alzheimer Disease Research Unit, McGill Center for Studies in Aging, commented: "Although much rarer than AD, bvFTD is a severely debilitating and rapidly progressive disease that is extremely distressing for families. The possibility of a new drug on the horizon in the form of hydromethylthionine for the first time offers a real hope for those affected."

About the Journal of Alzheimer's Disease (JAD)

Now in its 22nd year of publication, the Journal of Alzheimer's Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behaviour, treatment and psychology of Alzheimer's disease. The journal publishes research reports, reviews, short communications, book reviews and letters to the editor. Ground breaking research that has appeared in the journal includes novel therapeutic targets, mechanisms of disease and clinical trial outcomes. The Journal of Alzheimer's Disease has a 2018 Journal Impact Factor of 3.517 according to Journal Citation Reports (Web of Science Group, 2019). JAD is published by IOS Press. www.j-alz.com

About the Study

This study reports the results of a global Phase 3 trial in 220 patients with bvFTD conducted between 2013 and 2016 at 70 sites in 13 countries (Canada, United States, Australia, Asia, Europe). Patients had to be younger than 80 years of age and have a diagnosis bvFTD according to criteria revised by the International bvFTD Criteria Consortium1 with Mini-mental Status Examination score greater than or equal to 20 at screening. Patients were randomly assigned to receive hydromethylthionine at doses of 200 or 8 mg/day. The validated lower limit of quantification of the pharmacokinetic assay was 0.20 ng/mL, corresponding to an estimated steady-state peak plasma concentration of 0.346 ng/mL in bvFTD patients. About 35% of patients taking the 8 mg/day dose had plasma concentrations below this level.

About hydromethylthionine (LMTM) and protein aggregation inhibitors

TauRx's protein aggregation inhibitors have arisen from nearly 30 years of research. They work by preventing the abnormal aggregation process responsible for protein accumulations inside cells that impair neuronal function. The first-generation version of the drug, Rember was a patented, highly-purified version of methylthioninium chloride (methylene blue), a compound previously used to treat a variety of conditions. Methylene blue was previously shown to reduce aggregation of TDP-43 in cell models,6 and likewise for tau with both methylene blue and hydromethylthionine.7 Hydromethylthionine is a stable reduced form of methylthioninium, which is better absorbed8 than methylene blue and has been tested in clinical trials in mild-to-moderate Alzheimer's disease and in bvFTD. A 12-month placebo-controlled clinical trial for AD is currently ongoing at 150 sites in the US and EU.

About TauRx Therapeutics Ltd

TauRx Therapeutics Ltd is a member of the TauRx Pharmaceuticals group, which is developing technology spun-out from the University of Aberdeen, Scotland. The company was established in Singapore in 2002 with the aim of developing new treatments and diagnostics for a range of neurodegenerative diseases. The company's protein aggregation inhibitor, hydromethylthionine, targets aggregates of abnormal fibres of tau and TDP-43 proteins that form inside nerve cells in the brain. TauRx's headquarters are in Singapore and its primary research facilities are based in Aberdeen. For more information, please visit: http://www.taurx.com.

References

1. Rascovsky K, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.
Brain 2011;134:2456–2477.

2. Wischik CM, et al. Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease.
J Alzheimers Dis 2015;44:705–720.

3. Wilcock GK, et al. Potential of low dose leuco-methylthioninium bis(hydromethanesulphonate) (LMTM) monotherapy for treatment of mild Alzheimers disease: cohort analysis as modified primary outcome in a phase 3 clinical trial.
J Alzheimers Dis 2018;61:435–457.

4. Gauthier S, et al. Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial. Lancet 2016;388:2873–2884.

5. Schelter BO, et al. Concentration-dependent activity of hydromethylthionine on cognitive decline and brain atrophy in mild to moderate Alzheimer's disease. J Alzheimers Dis 2019;72:931–946.

6. Yamashita M, et al. Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models.
FEBS Lett 2009;583:2419–2424.

7. Harrington C, et al. Cellular models of aggregation-dependent template-directed proteolysis to characterize tau aggregation inhibitors for treatment of AlzheimerDisease. J Biol Chem 2015;290:10862–10875.

8. Baddeley TC, et al. Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease. J Pharmacol Exp Ther 2015;352:110–118.

Media Contacts

Alana Keating
+44(0)7795-432-022
Andrew Thomas
+44(0)7803-585-254
Email: Taurxpress@syneoshealth.com
Website: http://www.taurx.com


More News by PR Newswire India

SINOMED® Completes Last Patient Follow-Up of the PIONEER-III Pivotal US and Japanese Trial of the BuMA Supreme® Coronary Drug-Eluting Stent

Sage X3 V2020 R2 Released in India to Enable Indian Pharma Companies Enjoy the Benefits of Global Technology Platform

VIBGYOR Group of Schools Announces List of India's First Scholarship for Financially Affected Parents due to COVID-19 Pandemic

OctaFX Traders Help the Most Vulnerable Fight COVID-19

Infoblox Appoints George Chang as Vice President of Sales to Accelerate Growth in the Asia-Pacific Region

Empire State Building Grand Finale 44th Annual Macy's July 4th Fireworks® Spectacular

Fincasa Announces Global Online Investment Summit "Next Generation Visionaries"

Deakin University, Australia Announces Exclusive Academic Mentorship in Software Engineering for Indian Students

Burns & McDonnell India Ranks No. 6 on the Great Place to Work® List of 'India's Great Mid-Size Workplaces'

The Equitable Education Fund and 60 Educational Reformers Partner to Hold an Interntional Conference on Equity Education: ALL FOR EDUCATION

Apollo Proton Cancer Centre Receives Prestigious JCI Accreditation

OneWeb Announces HMG and Bharti Global Limited Consortium as Winning Bidders in Court-supervised Sale Process

OKEx-Adopted Global Utility Token OKB Reaches Cooperation With Coinrule and 5 Other New Ecosystem Partners

Afiniti Names Dame Jennifer Smith and Peter Riepenhausen to Its Board of Directors

OKEx Launches Latin American Fiat Gateway With Settle Network

'O Teacher Shukriya' Aims to Reach 10 million Views; EuroKids Dedicates Tribute to Teachers

World's Leading Multinationals are Preparing Engineering Professionals as per Industry Demand at Chandigarh University

Profectus Capital Partners With LeadSquared to Revolutionize SME Lending

BetBarter Signs Title Sponsorship Deal for Zambia Cricket League

Triller Hits 50M Monthly Active Users Surpassing TikTok's Reach At ByteDance Sale For 1 Billion

International Alliance for Responsible Drinking: CEOs of Leading Beer, Wine, and Spirits Producers Unite to Support the Rebuilding of the Thriving Cafe, Bar, and Restaurant Culture Missed by Communities

Godrej Security Solutions Launches UV Case; Expands Health Security Portfolio in India

Frost & Sullivan: Intelligent Pumps with Analytics Capabilities are Expected to be the New Norm

CoinPayments Selects Goodwin Procter LLP as Law Firm of Record, Targets Regulated Markets for Expansion & Increased Transparency

Xovis Multiplies Your Options in One Fell Swoop

Avaya Acclaimed by Frost & Sullivan for Elevating Contact Center Workforce Engagement Management with its OneCloud™ Portfolio

A Treat to Millions of Cricket Fans as Canada T20 Niagara Fest Comes Back on 16th July 2020 in Canada

The 127th Canton Fair Concludes, Establishing A New Trade Mechanism Online

Nitin Gadkari Inaugurates VVDN's Global Innovation Park (Technology Innovation, Engineering and Manufacturing Hub) at Manesar in India; PM Narendra Modi Sent his Best Wishes

Big Data Analytics Among Top Three Deployment Priorities for Enterprises, Says Frost & Sullivan

CEO of C Media Discusses Entrepreneurship And Disruptive AI & Automation Tools

Kotak & Innoviti in Pact to Offer EMIs on Kotak Debit Cards Swiped on Innoviti POS Terminals

Despite Global Pandemic and Recession - 4ARTechnologies is the First Start-up to Fulfil Its ICO Promises With Innovative Product Release and Exchange Listing

STEM Learning - Empowering the Teachers to Enable Better Learning Experience for the Students

HeiQ Viroblock Certified as Cosmetic Grade and Bio-based Renewable

CIIE: Cambodia Firms Believe Import Expo to Boost Trade and Investment

IIIT Hyderabad's Virtual Labs Hits 4 Million Page Views

Dome Entertainment Unveils New Interactive Fitness Platform - DFITZY

GCL SI Supports Floating Solar Power Plant in Persian Gulf

Edelweiss Tokio Life - Simply Protect: A Plan to Protect During Uncertainties

Affinity discovers potent SARS-CoV-2 antibodies

Cloud4C, World's Leading Cloud Managed Services Provider Launches its Operations in South Korea

Lear Recognized by General Motors as 2019 Supplier of the Year Winner

CF PharmTech, Inc. Closes a US $50M Series F Financing to Accelerate the Commercialization of its Inhalation Products.

Körber Unveils Next-Generation Sorter for Supply Chain Automation

Cyient Launches Empowering Tomorrow Together

TUMI Builds On Legacy Of Innovation Through Sustainability

NCCN: What People with Cancer and their Caregivers Need to Know about CAR T-Cell Therapy

REC Group Wins Prestigious Intersolar Award 2020 for its Powerful Alpha Solar Panels

LED High-beam Technology is the Future of Automotive Headlights in Europe

Thermo Fisher Scientific Launches New MAS Omni Infectious Disease Quality Controls

Svatantra's Home Insurance Helping Amphan Affected Rebuild Their Houses

Awards USD$1 Million Prize, HUAWEI HMS App Innovation Contest Goes Global

Zhejiang Export Online Fair Launches Business Matchmaking Program on Ball Bearings & Textile Machinery

Compuware Mainframe DevOps Integrations Further Automate Shift-left Testing

Exotel Helps Over 15,000 Agents Switch to Remote Work During the Pandemic, Powers Enterprises

Singapore Business Agency: Companies Eager to Attend CIIE

Marg ERP Launches 'My Shop QRID' to Maintain Social Distancing Between Buyer & Seller in COVID-19 Period

Clarivate Introduces Next Generation Insights Platform with Cortellis Generics Intelligence

CoinPayments Announces New Branding as Part of 2020 Growth Plans

Handheld Announces Major Upgrades to its Popular NAUTIZ X2 All-in-one Android Rugged Computer

Dr. Cipto Mangunkusumo Hospital Treats Indonesia's First Patient on Varian's Halcyon System

Skyscanner Reveals Five Tips for Travel Insurance Post COVID-19

Next Story Group Launches Safe With Us

How to Build Back a Low-Carbon Economy Globally: RMI Stimulus Series

Far East Hospitality Makes Bold Move with Official Opening of Far East Village Hotel Ariake

SecurityHQ, Formerly Known as Si Consult, Reveals New Brand Identity

INEOS Automotive Reveals the Design of Its Upcoming 4x4, the Grenadier

Almost Half of Children Are Not Always Using Soap When Washing Hands at School, New Survey by the Global Hygiene Council Finds

Small Businesses May Be Image Thieves Without Even Knowing It

Agora Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Overallotment Option

Frost & Sullivan Best Practices Awards Recognize the Asia-Pacific 2020 Leading Companies

SkyFoundry Commended by Frost & Sullivan for Its Groundbreaking Energy Management Platform, SkySpark®

Manipal Hospitals Performs Quadruple Valve Procedure for the First Time in Karnataka Amidst Pandemic

IMG Begins Fourth Annual 'Leave Your Mark' Global Outreach Essay Contest

ImageWare® Launches IP Licensing Monetization Program And Engages ipCapital Group

UNWTO and Sommet Education Offer 30 Scholarships Through "Hospitality Challenge"

SmartenApps Integrates Smarten Augmented Analytics With Shopify eCommerce for Data Analytics and Reporting

Shoolini University Gets QS Certification

Edelweiss Decodes Sustainability for MSMEs as Part of International MSME Day

One Drop Commended by Frost & Sullivan for Its Industry-leading Connected Glucose Meter and Smartphone Application

Pitamber Shivnani Appointed Managing Director & Chief Executive Officer of GE T&D India Limited

Zhejiang Hisun Pharmaceutical: COVID-19 Pandemic Brought Under Control in China With Favipiravir Showing Excellent Clinical Results

Manorama Industries YoY PAT up by 22%

Naver, Leading Online Search Platform in South Korea and Creator of the LINE Messenger App, Deploys Bright Pattern Contact Center Software

FarEye Partners With Blue Yonder to Enhance Logistics Execution, Collaboration, and Visibility

WeBank, Huawei and KPMG Share Insights on Fighting COVID - 19 with FinTech

Car Makers Ramp Up Electric Vehicle Production Capacity in Thailand, Investment Board Says

Averna Releases New Smart Data Management Solution

SAMSUNG SDI obtains a license from CAMX for its GEMX™ advanced battery cathode material platform

XCMG Foundation Machinery Completes Challenging Public Transportation Work, Aiding Regional Economical and Industrial Development

Chandigarh University Comes to Rescue of Indian Students Who Have the Dream of Studying Abroad

Sweeping Workplace Changes Expected in a Post-pandemic World, Says Research From The Adecco Group

Santen and Singapore's Health-tech Start-up, Plano Form a Strategic Alliance to Tackle the Global Burden of Myopia

The 2nd Edition of the Global Business Barometer Improves but Executives Still See the Economy and Their Businesses in the Survival Phase

Arman Financial Reports Highest Ever Annual Profit After Tax of ₹ 41.5 Crores in FY20

Clean Energy Can Support India's Economic Recovery post-COVID-19

Thrombosis Research Institute (TRI) Announce ETHIC Trial to Evaluate the Potential Benefits of Early Administration of LMWH in Patients with COVID-19

AOBiome Reports Successful Clinical Trials (Phase 2a in Adults and Phase 1b in Pediatrics) in Pruritus (Itch) Associated with Atopic Dermatitis: Initiates Phase 2b Clinical Trial in Adults

Bajaj Financial Securities Offers Equity F&O Trade at Flat Rs. 5 Per Order

Pantum Wins Bid to Supply Printers and Ensures After-Sales Services for Mahanadi Coalfields Limited

The Alliance to End Plastic Waste and China Petroleum and Chemical Industry Federation Partner to Jointly Tackle Plastic Waste in China

D-Link PoE Unmanaged Surveillance Switch Series Offers Solution that is Simple, Scalable, and Resilient

AVOXI Integrates Salesforce, Dynamics and Zoho Into Their Cloud Communications Platform

HighJump Named to SDCE 100 Top Supply Chain Projects for 2020

Wilbur-Ellis Kicks Off 100th Anniversary Celebration With New Website and Giving Program That Benefits the Red Cross

Clarivate Releases Web of Science Journal Citation Reports to Identify the World's Leading Journals

RevImmune Announces Phase II Trial of the T-Cell Growth Factor CYT107 for COVID-19

Acronis Lauded by Frost & Sullivan for its Breakthrough Integrated Data Protection Solution, Acronis Cyber Protect

How to Recognize Side-Effects from Immunotherapy? New NCCN Guidelines for Patients can Help

Viviana Mall Honours Excellence in Retail

Rajshri Entertainment's Bollywood Now is the 3rd Most Viewed Page on Facebook

RAGC - Helping Students to Keep Their Dreams Alive

Sunando Banerjee, The Gastronomic Engineering Cartoonist, Shares Insights on Future of Supply Chain

OKEx Lists COMP Governance Token From DeFi's Largest Platform Compound

Innoviti Enhances ESOP Pool to US $10 Million

Asia's First-ever Continuous Galvanized Rebar Manufacturing Facility Launched by Madhav KRG Group in Association With International Zinc Association, Initiative Supported by Hindustan Zinc Limited

But We Pray - The New E-book by AiR Helps Discover the True Meaning of Prayer

Home-hair Colouring Picks up Among Celebrities; Actress Neha Dhupia Gets Hair #ColourAtHome With Godrej Expert Rich Crème

Enjoy a Grape Escape to the Hunter Valley, New South Wales

ElcomSoft Certified: Digital Forensics Trainings and Trainer Certification Programs

D-Link 5G Solutions Revolutionize Mobile Connectivity

Xinhua Silk Road: online special feature on investment in south China's Hainan Jiangdong New Area launched

AsiaOne Recognizes Waaree as 'India's Greatest Brand' in Solar Industry

Invest Monthly in the Bajaj Finance Fixed Deposit to Grow Savings

Yuvraj Singh and OctaFX Help the Most Vulnerable Fight COVID-19

Hisense Air Conditioner Getting World's First JQA's Fresh Air Certification

Xinhua Silk Road: S. China's Guilin hosts events to celebrate Cultural and Natural Heritage Day

Chandigarh University Launches Financial Aid Program for the Meritorious and Deserving Students to Overcome Financial Crisis During COVID-19

Digital Health EMI Network Card - A Fully-digital Card by Bajaj Finance With Instant Activation

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
ICMR's claim to launch COVID-19 vaccine ...
Hyderabad man alleges private hospital r...
After Kanpur encounter, U'khand DG instr...
43 new coronavirus cases in Indore...
50-year-old man booked for raping minor ...
Charged Rs 1.15 lakh for 1 day Covid tre...
More...    
 
 Top Stories
Shivraj Chouhan meets Narendra Toma... 
Great guru and master for mankind: ... 
Chinese mainland reports 4 new conf... 
Vaani Kapoor shares her biggest les... 
US Ambassador to India wishes Dalai... 
Barcelona achieve 9,000 goals miles... 
Zafar Mirza, special adviser to Imr... 
Honda Siel Power Products to be kno...